|Inadequacy of plasma acyclovir levels at delivery in patients with genital herpes receiving oral acyclovir suppressive therapy in late pregnancy.|
|PMID: 20085679 Owner: NLM Status: MEDLINE|
|OBJECTIVE: Acyclovir therapy in late pregnancy among women with recurrent genital herpes is effective in decreasing genital lesion frequency and subclinical viral shedding rates at delivery, thereby decreasing the need for Caesarean section. Despite good adherence and increased dosing schedules, breakthrough lesions and viral shedding are still observed in some women at or near delivery. Anecdotal evidence suggests that low levels of herpes simplex virus replication at delivery may result in transmission to the neonate. Therefore, defining optimal acyclovir dosing during labour and delivery is warranted. Our objectives were to determine actual maternal and fetal acyclovir levels at delivery, and explore associations between acyclovir levels, duration of labour, and time since last acyclovir dose.
METHODS: Twenty-seven patients were prescribed oral acyclovir 400 mg three times daily from 36 weeks' gestation. Cord blood (venous and arterial) and maternal venous blood samples were collected at delivery, and acyclovir levels measured using capillary electrophoresis. Correlations between duration of labour, and time since last acyclovir dose with acyclovir blood levels were calculated.
RESULTS: Acyclovir levels were below the published mean steady-state trough value (180 ng/mL) in 52% of venous cord samples, 55% of arterial cord samples, and 36% of maternal samples. There was a significant inverse correlation between the time since last dose and venous cord levels (rs19 = -0.57, P < 0.015), arterial cord levels (rs16 = -0.63, P < 0.01), and maternal acyclovir levels (r10 = -0.69, P < 0.03).
CONCLUSION: Oral dosing of acyclovir in women in late pregnancy may result in insufficient levels at delivery to prevent viral shedding. Alternative approaches that incorporate acyclovir dosing through labour, either through oral or intravenous administration, should be evaluated to assess effects on viral shedding.
|Daniel T Leung; Paul A Henning; Emily C Wagner; Audrey Blasig; Anna Wald; Stephen L Sacks; Lawrence Corey; Deborah M Money|
Related Documents :
|18259899 - Impact of the severity of fetal distress on decision-to-delivery intervals for assisted...
11406079 - Relaxin for cervical ripening and induction of labour.
17599279 - Prediction of labour and delivery by ascertaining the fetal head position with transabd...
2317469 - Listeriosis revisited: the role of the obstetrician.
17468199 - Insights into the uterus.
18400139 - Maternal factors implicated in fetal bradycardia after combined spinal epidural for lab...
21809709 - Pattern of pregnancy weight gain in homozygous sickle cell disease and effect on birth ...
10483539 - Relationship between alpha-fetoprotein and fetal erythropoiesis.
19844939 - Noninvasive prenatal diagnosis of early onset primary dystonia i in maternal plasma.
|Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't|
|Title: Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstétrique et gynécologie du Canada : JOGC Volume: 31 ISSN: 1701-2163 ISO Abbreviation: J Obstet Gynaecol Can Publication Date: 2009 Dec|
|Created Date: 2010-01-20 Completed Date: 2010-02-26 Revised Date: 2014-09-08|
Medline Journal Info:
|Nlm Unique ID: 101126664 Medline TA: J Obstet Gynaecol Can Country: Canada|
|Languages: eng Pagination: 1137-43 Citation Subset: IM|
|APA/MLA Format Download EndNote Download BibTex|
administration & dosage*,
Antiviral Agents / administration & dosage*, blood
Dose-Response Relationship, Drug
Fetal Blood / chemistry
Herpes Genitalis / drug therapy*, prevention & control, transmission
Infectious Disease Transmission, Vertical / prevention & control*
Pregnancy Complications, Infectious / drug therapy*
|P01 AI030731/AI/NIAID NIH HHS; P01 AI030731-17/AI/NIAID NIH HHS; P01-AI30731/AI/NIAID NIH HHS|
|0/Antiviral Agents; X4HES1O11F/Acyclovir|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Caesarean section-past and present.
Next Document: Reproducibility of First Trimester Three-dimensional Placental Measurements in the Evaluation of Ear...